Related Experiment Video
Updated: Mar 6, 2026

09:45
On-Chip Octanol-Assisted Liposome Assembly for Bioengineering
Published on: March 17, 2023
3.6K
Automated and reconfigurable platform for niosome generation based on a microfluidic architecture
Summary
Researchers developed an automated microsystem for on-demand niosome generation. This microfluidic device produces nanoscale vesicles for localized drug delivery, achieving sizes as small as 91 nm.
Area of Science:
- Nanomedicine
- Regenerative Medicine
- Microfluidics
Background:
- Niosomes are crucial nanoscale vehicles for localized drug delivery in nanomedicine and regenerative medicine.
- Current methods for niosome generation can be complex and lack on-demand capabilities.
Purpose of the Study:
- To develop a novel automated microsystem for on-demand niosome generation.
- To investigate the influence of microchannel geometry on niosome size.
- To establish a low-cost fabrication process for the microsystem.
Main Methods:
- An automated microfluidic system was designed using three compact micropumps connected to a microfluidic substrate.
- Niosomes were formulated using cholesterol, dicetyl phosphate, and chloroform.
- The impact of 150 μm pseudo-Y and cross-shaped microchannels on vesicle diameter was evaluated.
- The system was fabricated using a low-cost dry photoresist process.
Main Results:
- The microsystem successfully generated niosome vesicles.
- A Y-shaped microchannel demonstrated reliable results, producing vesicles down to 91 nm in diameter.
- The use of cholesterol and dicetyl phosphate in chloroform yielded effective niosome formulations.
Conclusions:
- The developed automated microsystem offers a viable solution for on-demand niosome generation.
- Microfluidic technology, particularly Y-shaped channels, can precisely control nanoscale vesicle size for drug delivery.
- The low-cost fabrication approach makes this technology accessible for broader applications in nanomedicine.

